{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:25:39Z","timestamp":1782998739193,"version":"3.54.5"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.1001\/jamacardio.2024.2654","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T15:34:07Z","timestamp":1724859247000},"page":"957","source":"Crossref","is-referenced-by-count":4,"title":["Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection"],"prefix":"10.1001","volume":"9","author":[{"given":"Jessica A.","family":"Regan","sequence":"first","affiliation":[{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[{"name":"National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Selvaraj","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hed240008r1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"issue":"22","key":"hed240008r2","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2019.17935","article-title":"Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic\/Latino ancestry.","volume":"322","author":"Damrauer","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"hed240008r3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hed240008r4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41569-022-00683-z","article-title":"RNA-targeting and gene editing therapies for transthyretin amyloidosis.","volume":"19","author":"Aimo","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"hed240008r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.2190","article-title":"Prevalence, cardiac phenotype, and outcomes of transthyretin variants in the UK Biobank population.","author":"Aung","journal-title":"JAMA Cardiol"},{"issue":"19","key":"hed240008r6","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa2300792","article-title":"Actionable genotypes and their association with life span in Iceland.","volume":"389","author":"Jensson","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"hed240008r7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cardfail.2021.09.015","article-title":"Clinical implications of the amyloidogenic V122I transthyretin variant in the general population.","volume":"28","author":"Kozlitina","year":"2022","journal-title":"J Card Fail"},{"issue":"6","key":"hed240008r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2020.6623","article-title":"Association of the V122I transthyretin amyloidosis genetic variant with cardiac structure and function in middle-aged Black adults: Coronary Artery Risk Development in Young Adults (CARDIA) study.","volume":"6","author":"Sinha","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"4","key":"hed240008r9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis.","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hed240008r10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2021.04.042","article-title":"Atrial fibrillation and ischemic stroke with the amyloidogenic V122I transthyretin variant among Black Americans.","volume":"78","author":"Selvaraj","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hed240008r11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamacardio.2023.1525","article-title":"Age dependency of cardiovascular outcomes with the amyloidogenic pV142I transthyretin variant among Black individuals in the US.","volume":"8","author":"Selvaraj","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"21","key":"hed240008r12","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2024.4467","article-title":"Cardiovascular burden of the V142I transthyretin variant.","volume":"331","author":"Selvaraj","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"hed240008r13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly Black Americans.","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"hed240008r14","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41467-021-22876-9","article-title":"A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.","volume":"12","author":"Huda","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"hed240008r15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028534","article-title":"Design and rationale: the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) study.","volume":"12","author":"Ruberg","year":"2023","journal-title":"J Am Heart Assoc"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2822887\/jamacardiology_regan_2024_ed_240008_1730392602.88337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:40:28Z","timestamp":1731516028000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2822887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.2654","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}